12:00 pm – 1:00 pm
9th May
CHECK IN
1:00 pm – 1:30 pm
9th May
Laura Belver, Ph.D.
![BELVER LAURA_PHOTO](https://hematologyconference.ro/wp-content/uploads/2024/03/BELVER-LAURA_PHOTO.jpg)
Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukemia Research Institute, Barcelona, Spain.
1:30 pm – 2:00 pm
9th May
Nina Cabezas Wallscheid, Ph.D.
![CAZEBAS NINA_PHOTO](https://hematologyconference.ro/wp-content/uploads/2024/03/CAZEBAS-NINA_PHOTO-1.jpg)
Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany
2:00 pm – 2:30 pm
9th May
Gabriel Ghiaur, MD, Ph.D
![GHIAUR GABRIEL_PHOTO](https://hematologyconference.ro/wp-content/uploads/2024/02/GHIAUR-GABRIEL_PHOTO.jpg)
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA
2:30 pm – 3:00 pm
9th May
Sobi Symposium
![Ciprian Tomuleasa](https://hematologyconference.ro/wp-content/uploads/2024/04/Ciprian-Tomuleasa.jpeg)
Ciprian Tomuleasa M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Title: ITP treatment challenges and opportunities
Adina Traila M.D.
Title: Bridging the gap between expectation and reality in Haemophilia A
3:00 pm – 3:30 pm
9th May
AstraZeneca Symposium
![Delia Dima](https://hematologyconference.ro/wp-content/uploads/2024/04/Delia-Dima.jpeg)
Delia Dima, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy,Cluj-Napoca, Romania
Title: Relevant factors for clinical management in CLL / Aspecte relevante in managementul pacientilor cu LLC
3:30 pm – 4:10 pm
9th May
Johnson & Johnson Innovative Medicine Symposium
![Mariana V](https://hematologyconference.ro/wp-content/uploads/2024/04/Mariana-V.jpg)
Mariana Vasilica M.D.
Title: Ibrutinib and venetoclax – targeted combination therapy for first line CLL patients (post-ASH updates)
4:10 pm – 4:15 pm
9th May
Coffee Break
4:15 pm – 4:45 pm
9th May
Novartis Symposiums
![Delia Dima](https://hematologyconference.ro/wp-content/uploads/2024/04/Delia-Dima.jpeg)
Delia Dima, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy,Cluj-Napoca, Romania
4:45 pm – 5:05 pm
9th May
Takeda Symposiums
![Ciprian Tomuleasa](https://hematologyconference.ro/wp-content/uploads/2024/04/Ciprian-Tomuleasa.jpeg)
Ciprian Tomuleasa M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
5:05 pm – 5:25 pm
9th May
Astellas Symposium
![Ciprian Tomuleasa](https://hematologyconference.ro/wp-content/uploads/2024/04/Ciprian-Tomuleasa.jpeg)
Ciprian Tomuleasa M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Title: XOSPATA – Results from the Admiral & Steamline studies
5:25 pm – 5:45 pm
9th May
Roche Symposium
![Delia Dima](https://hematologyconference.ro/wp-content/uploads/2024/04/Delia-Dima.jpeg)
Delia Dima, M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy,Cluj-Napoca, Romania
5:45 pm – 6:15 pm
9th May
Swixx Biopharma Symposium
![Ciprian Tomuleasa](https://hematologyconference.ro/wp-content/uploads/2024/04/Ciprian-Tomuleasa.jpeg)
Ciprian Tomuleasa M.D.
Department of Hematology – Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Title: Translating the 2023 update of EORTC consensus recommendations for the treatment of mycosis fungoides & Sezary syndrome into practice: Opportunities and challenges with Poteligeo treatment